CHRISTINA NEUMEIER: Open Payments
NPI 1871244749 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 86 payments from 16 companies in 2025. Trend: 2023 $607 · 2024 $1,017 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $342 |
| Exact Sciences Corporation | 10 | $224 |
| Novo Nordisk Inc | 12 | $200 |
| ABBVIE INC. | 15 | $158 |
| Lilly USA, LLC | 7 | $120 |
| Abbott Laboratories | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| PFIZER INC. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
Products named: BREZTRI, Ozempic, The Cologuard Plus Collection Kit, MOUNJARO, UBRELVY, Cologuard Collection Kit, FREESTYLE LIBRE, CAPLYTA.
Industry payments across MO — which companies pay providers there.
